跳转至内容
Merck
所有图片(3)

Key Documents

MAB5206

Sigma-Aldrich

抗-淀粉样蛋白抗体,β 1-16,克隆DE2

culture supernatant, clone DE2, Chemicon®

别名:

Anti-AAA, Anti-ABETA, Anti-ABPP, Anti-AD1, Anti-APPI, Anti-CTFgamma, Anti-CVAP, Anti-PN-II, Anti-PN2, Anti-alpha-sAPP, Anti-preA4

登录查看公司和协议定价


About This Item

分類程式碼代碼:
12352203
eCl@ss:
32160702
NACRES:
NA.41

生物源

mouse

品質等級

抗體表格

culture supernatant

抗體產品種類

primary antibodies

無性繁殖

DE2, monoclonal

物種活性

monkey, bovine, human

製造商/商標名

Chemicon®

技術

ELISA: suitable
immunohistochemistry: suitable (paraffin)
western blot: suitable

同型

IgG

UniProt登錄號

運輸包裝

dry ice

目標翻譯後修改

unmodified

基因資訊

human ... APP(351)

應用

抗淀粉样蛋白抗体,β1-16,克隆DE2是一种针对淀粉样蛋白的抗体,用于ELISA、WB、IH(P)。
蛋白质印迹:1:10-1:300免疫组织化学:1:10-1:200在甲醛固定、石蜡包埋的组织上,需要甲酸或微波预处理来染色阿尔兹′海默病大脑老年斑。ELISA免疫沉淀

最佳工作稀释度必须由最终用户确定。

外觀

培养上清液。 含有0.02%叠氮化钠的液体。

法律資訊

CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany

未找到合适的产品?  

试试我们的产品选型工具.

儲存類別代碼

10 - Combustible liquids

水污染物質分類(WGK)

WGK 1


分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Mélanie Sipion et al.
Scientific reports, 13(1), 19828-19828 (2023-11-15)
Photobiomodulation (PBM), the process of exposing tissue to red or near-infrared light, has become a topic of great interest as a therapy for diverse pathologies, including neurodegenerative disorders. Here, we aimed to evaluate the potential beneficial effect of PBM on
Alexander J Ehrenberg et al.
Acta neuropathologica, 141(5), 651-666 (2021-03-08)
The farnesyltransferase inhibitor, Lonafarnib, reduces tau inclusions and associated atrophy in familial tauopathy models through activation of autophagy, mediated by the inhibition of farnesylation of the Ras GTPase, Rhes. While hinting at a role of Rhes in tau aggregation, it
S100A9 knockout decreases the memory impairment and neuropathology in crossbreed mice of Tg2576 and S100A9 knockout mice model.
Kim, HJ; Chang, KA; Ha, TY; Kim, J; Ha, S; Shin, KY; Moon, C; Nacken, W; Kim, HS; Suh, YH
Testing null
Avindra Nath et al.
Neuromolecular medicine, 3(1), 29-39 (2003-04-01)
Studies of amyloid precursor protein transgenic mice suggest that immune responses to amyloid beta peptide (Abeta) may be instrumental in the removal of plaques from the brain, but the initial clinical trial of an Abeta vaccine in patients with Alzheimer
Tomàs Jordà-Siquier et al.
Alzheimer's & dementia : the journal of the Alzheimer's Association, 18(11), 2099-2116 (2022-01-26)
In Alzheimer's disease (AD), the distribution of the amyloid precursor protein (APP) and its fragments other than amyloid beta, has not been fully characterized. Here, we investigate the distribution of APP and its fragments in human AD brain samples and

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门